Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol

NCT00640614 is registered in ClinicalTrials.gov with Allerderm as lead sponsor.

NCT NCT00640614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00640614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol
Lead sponsor
Allerderm
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2008
Completion date
October 31, 2009
Enrollment
235 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

contact dermatitis